Innocoll AG (INNL) Misses Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St slips as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Bloom Energy shares fall on Oracle project halt
Enanta Pharma (ENTA) Adds Innocoll Holdings' Russell as Director
November 22, 2016 7:40 AM ESTEnanta Pharmaceuticals, Inc. (Nasdaq: ENTA) announced the appointment of Lesley Russell, MBChB, MRCPb, to its Board of Directors. Dr. Russell will also serve as a member of Enantas audit committee and its nominating and corporate governance committee, effective as of January 1, 2017.
Dr. Russell has over two decades of clinical, regulatory and drug development expertise in the therapeutic areas of hematology/oncology, neurology, psychiatry, pain and inflammation, respiratory medicine, cardiovascular medicine, virology and stem cell therapy. Throughout her career and under her leadership, she has advanced multiple drug candidates from preclinical development, through the... More
